Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ohno

Showing results (381-390 of 400) with videos related to

Pageof 40
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1978
[Treatment of therapy-resistant acute non-lymphocytic leukemia with PADOC (author's transl)]H Yoshikawa, T Uetani, F Sako, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|November 1, 1982
[Allogeneic bone marrow transplantation in 14 cases of leukemia]H Yamada, H Yamaguchi, Y Morishima, et al.
Leukemia|October 15, 2010
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemiaS Mizuta, K Matsuo, F Yagasaki, et al.
Blood|April 6, 2001
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesY Yamamoto, H Kiyoi, Y Nakano, et al.
Leukemia|September 26, 1997
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)H Kiyoi, T Naoe, S Yokota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemiaT Naoe, K Takeyama, T Yokozawa, et al.
International Journal of Hematology|January 14, 1999
Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)M Tanimoto, S Miyawaki, T Ino, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1980
[DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)]Y Morishima, K Yamada, K Kawashima, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)N Asou, K Adachi, U Tamura, et al.
International Journal of Hematology|December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study GroupT Ueda, S Miyawaki, N Asou, et al.
Pageof 40

Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1978
[Treatment of therapy-resistant acute non-lymphocytic leukemia with PADOC (author's transl)]H Yoshikawa, T Uetani, F Sako, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|November 1, 1982
[Allogeneic bone marrow transplantation in 14 cases of leukemia]H Yamada, H Yamaguchi, Y Morishima, et al.
Leukemia|October 15, 2010
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemiaS Mizuta, K Matsuo, F Yagasaki, et al.
Blood|April 6, 2001
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesY Yamamoto, H Kiyoi, Y Nakano, et al.
Leukemia|September 26, 1997
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)H Kiyoi, T Naoe, S Yokota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemiaT Naoe, K Takeyama, T Yokozawa, et al.
International Journal of Hematology|January 14, 1999
Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)M Tanimoto, S Miyawaki, T Ino, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1980
[DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)]Y Morishima, K Yamada, K Kawashima, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)N Asou, K Adachi, U Tamura, et al.
International Journal of Hematology|December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study GroupT Ueda, S Miyawaki, N Asou, et al.
Pageof 40